Find an Expert
Search
Menu
Help
Report an issue
A randomized, placebo-controlled, double-masked, multicenter, dose-ranging study to evaluate the safety, and efficacy of UNR844 in subjects with presbyopia
| Funding period: 2021 - 2023
Active
University of Melbourne Researchers
Laura Downie
Optometry and Vision Sciences